Medical Research & Talent|October 15, 2021
Kipp Weiskopf—who is identifying ways to prompt macrophages to fight cancer—has been named a Valhalla Fellow.
Medical Research & Talent|September 2, 2021
Kristin Knouse joined the Massachusetts Institute of Technology (MIT) faculty as an assistant professor of biology and a member of MIT’s Koch Institute for Integrative Cancer. As a Scott Cook and Signe Ostby Fellow at the Whitehead Institute since 2018, Knouse worked to understand how tissues sense and respond to damage.
Medical Research & Talent|June 15, 2021
The founders of Fast Grants share insights from developing and operating a rapid funding platform for COVID-19 scientific research.
Medical Research & Talent|June 3, 2021
Dr. Joe DeRisi, a UCSF Sandler Fellow alumnus, invented a way to find pathogens that scientists didn't even know to look for. Can it help prevent the next pandemic?
Medical Research & Talent|April 28, 2021
Researchers at UCSF have demonstrated how to engineer smart immune cells that are effective against solid tumors, opening the door to treating a variety of cancers that have long been untouchable with immunotherapies.
Medical Research & Talent|November 20, 2020
At Whitehead Institute, Tobi Oni will focus on uncovering mechanisms for the poor anti-tumor immune response to pancreatic cancer, and work to develop novel ways of promoting tumor clearance by immune cells. And—following in his mother’s footsteps—he will pursue opportunities to inspire and mentor the next generation of scientists from diverse backgrounds.
Medical Research & Talent|March 28, 2017
The drug, ocrelizumab, is one of three new "B-cell" therapies to treat MS that have proven to be extremely effective in preventing MS relapses.